Dr. Jaime Jacqueline Jayapalan is a distinguished Senior Lecturer at Universiti Malaya's Department of Molecular Medicine, with a rich background in academia and research, including international experience in Sri Lanka and India. She embarked on her academic career with a First Class Honours degree in Biomedical Science from Universiti Sains Malaysia in 2005, followed by a master's in Medical Sciences from Universiti Malaya in 2009. She further enhanced her qualifications with a PhD in Biochemistry/Proteomics in 2015 and an MBA in Human Resource Management in 2021, both from Universiti Malaya. Dr. Jayapalan has demonstrated a strong capability in securing research grants, contributing significantly to advancements in her field, particularly in identifying disease biomarkers and investigating biochemical changes in diseases like prostate cancer and pancreatic ductal adenocarcinoma. Her scholarly work, which includes over 725 citations and an H-index of 16, underscores her impactful contributions to molecular medicine.
Research Keywords & Expertise
Biomarker Discovery
Cancer
Glycosylation
Proteomics
Lectin
Fingerprints
61%
Cancer
25%
Proteomics
25%
Lectin
20%
Biomarker Discovery
18%
Glycosylation
Short Biography
Dr. Jaime Jacqueline Jayapalan is a distinguished Senior Lecturer at Universiti Malaya's Department of Molecular Medicine, with a rich background in academia and research, including international experience in Sri Lanka and India. She embarked on her academic career with a First Class Honours degree in Biomedical Science from Universiti Sains Malaysia in 2005, followed by a master's in Medical Sciences from Universiti Malaya in 2009. She further enhanced her qualifications with a PhD in Biochemistry/Proteomics in 2015 and an MBA in Human Resource Management in 2021, both from Universiti Malaya. Dr. Jayapalan has demonstrated a strong capability in securing research grants, contributing significantly to advancements in her field, particularly in identifying disease biomarkers and investigating biochemical changes in diseases like prostate cancer and pancreatic ductal adenocarcinoma. Her scholarly work, which includes over 725 citations and an H-index of 16, underscores her impactful contributions to molecular medicine.